All
Smoking Cessation Programs Help Reduce Bladder Cancer Risk in Older Women
May 15th 2019A recent study showed that postmenopausal women demonstrated a significant reduction in the risk for bladder cancer after quitting smoking, highlighting the need for prevention and cessation programs in older women.
Food and Drug Administration Panel Supports Pexidartinib for Tenosynovial Giant Cell Tumor
May 14th 2019The FDA’s Oncologic Drugs Advisory Committee voted in favor of the agency approving pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor – a rare, benign lesion that can be locally aggressive and often recurring.
Severe Hearing Loss from Pediatric Brain Tumor Treatment May Cause Cognitive Difficulties
May 13th 2019Children diagnosed with embryonal brain tumors who have experienced treatment-related hearing loss exhibited greater difficulties reading – in particular, with phonological skills and processing speed, according to study results.
Prostate Cancer Foundation's Robust Collection of New Patient Resources Now Available
May 13th 2019The Prostate Cancer Foundation announced the newly revised 2019 Prostate Cancer Patient Guide, a comprehensive resource for diagnosis, treatment, side effects, survivorship, and risk factors for patients and families with a history of prostate cancer.
Opdivo Plus Radiation Fails to Prolong Survival in Subtype of Glioblastoma
May 9th 2019The phase 3 CheckMate 498 trial, designed to compare Opdivo with Temodal for the treatment of patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme failed to meet its primary endpoint of increasing overall survival.